Showing results (71-80 of 308) with videos related to
Sort By:
Pageof 31
Current Pharmaceutical Design|May 2, 2000
Design and evaluation of hepatitis B virus inhibitorsO Hantz, J L Kraus, F ZoulimRevue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1979
[Gingivectomies. Flap operations (author's transl)]J P MerleLa Nouvelle Presse Medicale|September 11, 1976
[Detection and prognostic significance of Ag "e" and its antibody in the course of HB virus infections[]D Trépo, C Trépo, A Jouvenceaux, et al.Archives of Virology. Supplementum|January 1, 1992
PCR detection of HCV RNA among French non-A, non-B hepatitis patientsJ Li, L Vitvitski, S Tong, et al.Antiviral Research|October 24, 2001
Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver diseaseI Chemin, D Jeantet, A Kay, et al.Journal of Medical Virology|January 1, 1980
Two low molecular weight peptides as common determinants to different molecular forms and specificities of hepatitis B e antigen (HBeAg)B Blanchy, O Hantz, L Vitvitski, et al.Journal of Hepatology|February 1, 1996
Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBcF Zoulim, X Zhang, C Pichoud, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Treatment of human immunodeficiency virus and hepatitis B virus infectionsF Zoulim, F Bailly, M Johnson, et al.Reviews in Medical Virology|January 8, 2003
Clinical consequences of hepatitis C virus infectionF Zoulim, M Chevallier, M Maynard, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 18, 2011
[Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma]P Merle, F MornexPageof 31